Clinical Trial Update: Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR [NA]

View source ↗

Summary

A clinical trial update shows CT-ACL001, a regenerative ligament using biological tissue, is currently enrolling by invitation for anterior cruciate ligament ru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Rupture

Drugs mentioned

• CT-ACL001

Snippet

Sponsor: CoreTissue BioEngineering Inc. | Conditions: Anterior Cruciate Ligament Rupture | NA | Status: ENROLLING_BY_INVITATION